82 related articles for article (PubMed ID: 17956291)
1. Regulation of T-cell migration by co-stimulatory molecules.
David R; Marelli-Berg FM
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1114-8. PubMed ID: 17956291
[TBL] [Abstract][Full Text] [Related]
2. The highway code of T cell trafficking.
Marelli-Berg FM; Cannella L; Dazzi F; Mirenda V
J Pathol; 2008 Jan; 214(2):179-89. PubMed ID: 18161751
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation.
Ward SG; Marelli-Berg FM
Biochem J; 2009 Feb; 418(1):13-27. PubMed ID: 19159344
[TBL] [Abstract][Full Text] [Related]
4. Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis.
Buono C; Lichtman AH
Trends Cardiovasc Med; 2004 May; 14(4):166-72. PubMed ID: 15177268
[TBL] [Abstract][Full Text] [Related]
5. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic manipulation of T cell chemotaxis in transplantation.
Yopp AC; Krieger NR; Ochando JC; Bromberg JS
Curr Opin Immunol; 2004 Oct; 16(5):571-7. PubMed ID: 15342001
[TBL] [Abstract][Full Text] [Related]
7. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
[TBL] [Abstract][Full Text] [Related]
8. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4: acting at the synapse.
Chikuma S; Bluestone JA
Mol Interv; 2002 Jul; 2(4):205-8. PubMed ID: 14993389
[No Abstract] [Full Text] [Related]
10. Natural immunity has significant impact on immune responses against cancer.
Rubin B
Scand J Immunol; 2009 Mar; 69(3):275-90. PubMed ID: 19281540
[TBL] [Abstract][Full Text] [Related]
11. Chemokine control of lymphocyte trafficking: a general overview.
Stein JV; Nombela-Arrieta C
Immunology; 2005 Sep; 116(1):1-12. PubMed ID: 16108812
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alloimmune responses by dendritic cell subsets.
Lonial S; Torre C; David E; Harris W; Arellano M; Waller EK
Exp Hematol; 2008 Oct; 36(10):1309-17. PubMed ID: 18620796
[TBL] [Abstract][Full Text] [Related]
13. Src homology 2-domain containing leukocyte-specific phosphoprotein of 76 kDa is mandatory for TCR-mediated inside-out signaling, but dispensable for CXCR4-mediated LFA-1 activation, adhesion, and migration of T cells.
Horn J; Wang X; Reichardt P; Stradal TE; Warnecke N; Simeoni L; Gunzer M; Yablonski D; Schraven B; Kliche S
J Immunol; 2009 Nov; 183(9):5756-67. PubMed ID: 19812192
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
[TBL] [Abstract][Full Text] [Related]
15. Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells.
Al-Hamidi A; Pekalski M; Robertson H; Ali S; Kirby JA
Mol Immunol; 2008 Sep; 45(15):4000-7. PubMed ID: 18649941
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of leukocyte trafficking in T-cell-mediated skin inflammation: insights from intravital imaging.
Deane JA; Hickey MJ
Expert Rev Mol Med; 2009 Aug; 11():e25. PubMed ID: 19691914
[TBL] [Abstract][Full Text] [Related]
17. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
[TBL] [Abstract][Full Text] [Related]
18. How polarity shapes the destiny of T cells.
Russell S
J Cell Sci; 2008 Jan; 121(Pt 2):131-6. PubMed ID: 18187446
[TBL] [Abstract][Full Text] [Related]
19. Histochemical and molecular overview of the thymus as site for T-cells development.
Rezzani R; Bonomini F; Rodella LF
Prog Histochem Cytochem; 2008; 43(2):73-120. PubMed ID: 18555891
[TBL] [Abstract][Full Text] [Related]
20. Tick saliva inhibits the chemotactic function of MIP-1alpha and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5.
Oliveira CJ; Cavassani KA; Moré DD; Garlet GP; Aliberti JC; Silva JS; Ferreira BR
Int J Parasitol; 2008 May; 38(6):705-16. PubMed ID: 18023445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
